Choice launched sLINJ on October 30, 2026, giving holders leveraged exposure to INJ staking with a target annual yield of approximately 12% paid in INJ. Issued by MidasRWA on Injective EVM, the product combines multiple staking positions into a single instrument and accepts deposits in INJ, WINJ or yINJ. It charges a 1% annual management fee and a 15% performance fee on the staking yield earned. Redemptions are instant when liquidity permits but take approximately three days under the standard model. The launch drew little market commentary and is primarily aimed at decentralized-finance users on Injective.
Source: Read the original article
Disclaimer: this content is for information purposes only and is not financial advice. Cryptocurrencies are highly volatile: you may lose all of your capital. Always do your own research. Legal notice
